Outer membrane vesicle (OMV) engineeringg involves the genetic and biochemical modification of bacterial-derived nanoscale vesicles to serve as customizable drug delivery platforms. By leveraging their native immunostimulatory properties and high surface functionalization capacity, OMV engineering facilitates targeted CAR-T cell infiltration into solid tumors through enhanced chemokine-guided trafficking and extracellular matrix remodeling.
